1. Clinical use of biomarkers in the field of cytotoxic nucleoside analogues
   Lars Petter Jordheim, 2023, Nucleosides, Nucleotides & Nucleic Acids CrossRef
2. Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians
   Dimitrios Giannis et al, 2021, Cancers CrossRef
3. Tailored adjuvant gemcitabine versus 5-fluorouracil/folinic acid based on hENT1 immunohistochemical staining in resected pancreatic ductal adenocarcinoma: A biomarker stratified prospective trial
   Dong Woo Shin et al, 2021, Pancreatology CrossRef
4. Personalized treatment using predictive biomarkers in solid organ malignancies: A review
   Haoming Tang et al, 2024, Tumori Journal CrossRef
5. The Dihydroorotate Dehydrogenase Inhibitor Brequinar Is Synergistic with ENT1/2 Inhibitors
   Christine R. Cuthbertson et al, 2020, ACS Pharmacology & Translational Science CrossRef
6. Molecular biomarkers in pancreatic ductal adenocarcinoma
   Junya Tsuboi et al, 2024, Biomarkers in Cancer Detection and Monitoring of Therapeutics CrossRef
7. Predictive and Prognostic Properties of Human Equilibrative Nucleoside Transporter 1 Expression in Gemcitabine-Treated Pancreatobiliary Cancer: A Meta-Analysis
   Larissa J. Vos et al, 2019, JCO Precision Oncology CrossRef